Arinna Bertoni

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Nlrp Inflammasome

Top Venues

Life science alliance

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Lieselotte Vande Walle, Madhukar Said, Oonagh Paerewijck, Arinna Bertoni, Marco Gattorno, Bruno Linclau, Mohamed Lamkanfi
Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with high potency. Life science alliance 7 (6) (2024)
Lieselotte Vande Walle, Madhukar Said, Oonagh Paerewijck, Arinna Bertoni, Marco Gattorno, Bruno Linclau, Mohamed Lamkanfi
Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with high potency. Life science alliance 7 (6) (2024)
Lieselotte Vande Walle, Madhukar Said, Oonagh Paerewijck, Arinna Bertoni, Marco Gattorno, Bruno Linclau, Mohamed Lamkanfi
Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with high potency. Life science alliance 7 (6) (2024)
Lieselotte Vande Walle, Madhukar Said, Oonagh Paerewijck, Arinna Bertoni, Marco Gattorno, Bruno Linclau, Mohamed Lamkanfi
Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with high potency. Life science alliance 7 (6) (2024)
Lotte Spel, Cyrielle Hou, Katerina Theodoropoulou, Léa Zaffalon, Zhuo Wang, Arinna Bertoni, Stefano Volpi, Michaël Hofer, Marco Gattorno, Fabio Martinon
HSP90β controls NLRP3 autoactivation. Science advances 10 (9) (2024)
Lotte Spel, Cyrielle Hou, Katerina Theodoropoulou, Léa Zaffalon, Zhuo Wang, Arinna Bertoni, Stefano Volpi, Michaël Hofer, Marco Gattorno, Fabio Martinon
HSP90β controls NLRP3 autoactivation. Science advances 10 (9) (2024)